News

NHS detects tens of thousands of bowel cancers thanks to screening programme

Millions more people are now benefiting from lifesaving bowel screening compared to a decade ago, as the NHS urges even more people to get tested. Almost 7 million people have had bowel screening from the NHS during 2024/25, compared to around 4.7 million in 2014/15. Since bowel screening started 2 decades ago, the NHS has […]

Read more

March was busiest month ever for A&Es amid meningitis outbreak

A&E waiting times have fallen to a five-year low, despite the NHS seeing record numbers of patients in March as the health service experienced a ‘prolonged winter’. There were a record breaking 2.43 million total A&E attendances in March – 16,000 more than the previous record high in May 2024. Despite the bumper demand, almost […]

Read more

NHS launches trailblazing AI and robot pilot to spot lung cancer sooner alongside screening programme set to tackle cancer inequalities

Patients facing suspected lung cancer could get answers sooner under a new NHS pilot using artificial intelligence and robotic technology to help doctors reach hard-to-detect cancers earlier, with fewer invasive tests.  The new approach uses AI software to rapidly analyse lung scans and flag small lumps that are most likely to be cancerous, and a robotic camera is then used to […]

Read more

NHS to offer thousands of men life-extending prostate cancer drug

Thousands of men with prostate cancer will be offered a life-extending drug on the NHS within weeks. For the first time patients whose prostate cancer has not spread will be able to receive the drug in England, known as abiraterone, as the health service widens access to the treatment. Around 2,000 men diagnosed with prostate […]

Read more

Hundreds more blood cancer patients to receive life-giving drug on NHS

Hundreds more people with an aggressive form of blood cancer can now be offered hope of a cure and “a new lease of life” from today thanks to an NHS drug rollout. Glofitamab (Columvi®) will now be offered to around 300 people a year with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) — a […]

Read more